These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 18657182)

  • 21. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
    Hasanein P; Shahidi S; Komaki A; Mirazi N
    Eur J Pharmacol; 2008 Sep; 591(1-3):132-5. PubMed ID: 18593578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease.
    Bisogno T; Martire A; Petrosino S; Popoli P; Di Marzo V
    Neurochem Int; 2008 Jan; 52(1-2):307-13. PubMed ID: 17664017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The endocannabinoid-CB(1) receptor system in pre- and postnatal life.
    Fride E
    Eur J Pharmacol; 2004 Oct; 500(1-3):289-97. PubMed ID: 15464041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors.
    Braun A; Engel T; Aguilar-Pimentel JA; Zimmer A; Jakob T; Behrendt H; Mempel M
    Immunobiology; 2011 Apr; 216(4):466-76. PubMed ID: 21056512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of receptors for endocannabinoids in human and rodent skeletal muscle.
    Cavuoto P; McAinch AJ; Hatzinikolas G; Janovská A; Game P; Wittert GA
    Biochem Biophys Res Commun; 2007 Dec; 364(1):105-10. PubMed ID: 17935697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
    Martin BR
    Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocannabinoids in the immune system and cancer.
    Parolaro D; Massi P; Rubino T; Monti E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):319-32. PubMed ID: 12052046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
    Pryce G; Baker D
    Handb Exp Pharmacol; 2015; 231():213-31. PubMed ID: 26408162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
    Svízenská I; Dubový P; Sulcová A
    Pharmacol Biochem Behav; 2008 Oct; 90(4):501-11. PubMed ID: 18584858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
    Iribarne M; Torbidoni V; Julián K; Prestifilippo JP; Sinha D; Rettori V; Berra A; Suburo AM
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4535-44. PubMed ID: 18566465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Latest advances in cannabinoid receptor agonists.
    Thakur GA; Tichkule R; Bajaj S; Makriyannis A
    Expert Opin Ther Pat; 2009 Dec; 19(12):1647-73. PubMed ID: 19939187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats.
    ; De Filippis D; D'Amico A; Cipriano M; Petrosino S; Orlando P; Di Marzo V; Iuvone T
    Pharmacol Res; 2010 Apr; 61(4):321-8. PubMed ID: 19931394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
    Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
    Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals.
    Re G; Barbero R; Miolo A; Di Marzo V
    Vet J; 2007 Jan; 173(1):21-30. PubMed ID: 16324856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in the endocannabinoid system in the rat valproic acid model of autism.
    Kerr DM; Downey L; Conboy M; Finn DP; Roche M
    Behav Brain Res; 2013 Jul; 249():124-32. PubMed ID: 23643692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antinociceptive effects of local injections of propofol in rats are mediated in part by cannabinoid CB1 and CB2 receptors.
    Guindon J; LoVerme J; Piomelli D; Beaulieu P
    Anesth Analg; 2007 Jun; 104(6):1563-9, table of contents. PubMed ID: 17513659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
    Wilkerson JL; Bilbrey JA; Felix JS; Makriyannis A; McMahon LR
    Pharmacol Biochem Behav; 2021 Jul; 206():173192. PubMed ID: 33932409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocannabinoid System Contributes to Liver Injury and Inflammation by Activation of Bone Marrow-Derived Monocytes/Macrophages in a CB1-Dependent Manner.
    Mai P; Yang L; Tian L; Wang L; Jia S; Zhang Y; Liu X; Yang L; Li L
    J Immunol; 2015 Oct; 195(7):3390-401. PubMed ID: 26320250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
    Smith PF
    Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.